e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Tuberculosis, pneumonia and vaccinations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Study of the prevalence of
Moraxella (Branhamella) catarrhalis
in the patients suffering from lower respiratory tract infection
A. Farajzadeh Sheikh, A. Dezfulian, M. A. Tabbe (Ahwaz, Islamic Republic Of Iran)
Source:
Annual Congress 2005 - Tuberculosis, pneumonia and vaccinations
Session:
Tuberculosis, pneumonia and vaccinations
Session type:
Thematic Poster Session
Number:
959
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Farajzadeh Sheikh, A. Dezfulian, M. A. Tabbe (Ahwaz, Islamic Republic Of Iran). Study of the prevalence of
Moraxella (Branhamella) catarrhalis
in the patients suffering from lower respiratory tract infection. Eur Respir J 2005; 26: Suppl. 49, 959
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
The impact of antibiotic resistance in the management of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131
Year: 2004
Antibiotic resistance of
Streptococcus pneumoniae
and
Haemophilus influenzae
strains isolated from community-aquired inferior respiratory tract infections in Romania
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis
Source: Eur Respir J 2007; 29: 1127-1137
Year: 2007
Microbiology of non-CF bronchiectasis
Source: Eur Respir Mon 2011; 52: 68-96
Year: 2011
Resistance of respiratory tract Streptococcus pneumoniae strains
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002
The response of macrophages to Moraxella catarrhalis infection
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
Monitoring of
Mycoplasma pneumoniae
and
Chlamydia pneumoniae
in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001
Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Penicillin resistance rates for streptococcus pneumoniae strains isolated from lower respiratory tract infections
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002
Mycoplasma pneumoniae genotype is associated with severity of lower respiratory tract infections in children
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017
Moraxella catarrhalis infection of healthy and COPD ciliated epithelial cultures
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia
Source: Eur Respir J 2001; 17: 241-245
Year: 2001
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Levofloxacin non-susceptible
streptococcus pneumoniae
in community-acquired respiratory infection; prevalence and risk factors
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Chlamidia pneumoniae
and
Mycoplasma pneumoniae
infection of airways in patients with broncho-obstructive diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 409s
Year: 2005
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia
Source: Eur Respir J 2011; 37: 1522-1524
Year: 2011
Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Antibiotic susceptibility testing on
streptococcus pneumoniae
strains obtained from respiratory tract specimens
Source: Eur Respir J 2001; 18: Suppl. 33, 139s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept